查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1545565

恒温核酸增幅技术（INAAT）的全球市场

Isothermal Nucleic Acid Amplification Technology (INAAT)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球等恒温核酸增幅技术 (INAAT) 市场将达到 67 亿美元

恒温核酸增幅技术 (INAAT) 的全球市场预计 2023 年为 34 亿美元，预计到 2030 年将达到 67 亿美元，2023 年至 2030 年复合年增长率为 10.3%。 INAAT 试剂是本报告分析的细分市场之一，预计复合年增长率为 10.1%，到分析期结束时将达到 46 亿美元。分析期间内，INAAT 设备领域的复合年增长率预计为 10.7%。

美国市场预估为8.983亿美元，中国预期复合年增长率为9.7%

预计2023年美国恒温核酸增幅技术（INAAT）市场规模为8.983亿美元。中国作为全球第二大经济体，预计2030年市场规模将达10亿美元，2023-2030年分析期间复合年增长率为9.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 9.2% 和 8.6%。在欧洲，德国的复合年增长率预计约为 8.0%。

全球恒温核酸增幅技术 (INAAT) 市场 – 主要趋势与驱动因素总结

为什么恒温核酸增幅技术 (INAAT) 会彻底改变分子诊断？

恒温核酸增幅技术（INAAT）透过提供不需要热感的快速、灵敏、特异性的核酸检测方法正在彻底改变分子诊断领域。与传统 PCR 技术不同，INAAT 在恆温下运行，简化了所需设备并缩短了获得结果的时间。该技术在快速、准确的诊断至关重要的护理点环境中特别有用。 INAAT 已广泛应用于感染疾病、遗传疾病和癌症生物标记的检测，使其成为现代医疗保健的重要工具。 INAAT 能够快速、高精度地产生结果，使其在常规临床诊断中得到越来越多的采用，特别是在资源匮乏、先进测试基础设施访问有限的环境中。

科技进步如何增强 INAAT 的能力？

技术进步显着增强了 INAAT 的功能，使其更加强大、多功能且易于使用。酵素设计和反应化学方面的创新提高了 INAAT 检测的灵敏度和特异性，使其能够检测复杂生物样品中的低水平核酸。此外，结合 INAAT 的可携式、易于使用的设备的开发扩大了其在现场诊断和家庭测试中的用途。这些进步对于对抗新出现的感染疾病特别有影响力，其中快速和分散的检测至关重要。此外，INAAT 与数位技术和资料分析的集合成为即时监测疾病爆发和个人化医疗开闢了新的可能性。这些技术进步正在推动 INAAT 在从公共卫生到个人化医疗等各个领域的采用。

INAAT市场存在哪些挑战与机会？

儘管 INAAT 的应用日益广泛，但 INAAT 市场仍面临多项挑战，包括标准化需求、监管障碍以及现有分子诊断技术的竞争。不同 INAAT 平台之间缺乏标准化方案和试剂可能会导致结果差异，这是临床应用的问题。此外，诊断测试的严格监管要求可能会延迟新 INAAT 产品的商业化，特别是在美国和欧洲等监管严格的市场。然而，这些挑战也带来了创新和市场成长的机会。能够开发标准化、易于使用的 INAAT套件并获得广泛监管核准的公司将能够利用快速诊断不断增长的需求。此外，感染疾病控制、癌症筛检和个人化医疗等领域对改进诊断工具的持续需求继续推动人们对 INAAT 的兴趣和投资。

推动INAAT市场成长的因素有哪些？

恒温核酸增幅技术（INAAT）市场的成长受到多种因素的推动，例如对快速且准确诊断的需求不断增加、感染疾病的流行以及分子生物学的进步。对就地检验的需求不断增长，特别是在 COVID-19 大流行等全球健康危机中，凸显了快速可靠的诊断工具的重要性，推动了 INAAT I am 的采用。此外，INAAT 应用扩展到传染病检查之外，例如肿瘤学和基因检测，也有助于市场成长。提高 INAAT 平台性能和易用性的技术进步也发挥了关键作用，使其能够在从临床实验室到偏远地区的各种环境中广泛采用。随着医疗保健系统不断强调早期诊断和个人化治疗的重要性，对 INAAT 的需求预计将增长，从而推动进一步的进步和市场扩张。

受访企业范例（12家知名企业）

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies（Hangzhou）Ltd.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12875

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach US$6.7 Billion by 2030

The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$3.4 Billion in the year 2023, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the INAAT Instruments segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$898.3 Million While China is Forecast to Grow at 9.7% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$898.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Key Trends & Drivers Summarized

Why Is Isothermal Nucleic Acid Amplification Technology (INAAT) Revolutionizing Molecular Diagnostics?

Isothermal Nucleic Acid Amplification Technology (INAAT) is revolutionizing the field of molecular diagnostics by providing a rapid, sensitive, and specific method for detecting nucleic acids without the need for thermal cycling. Unlike traditional PCR techniques, INAAT operates at a constant temperature, simplifying the equipment required and reducing the time to results. This technology is particularly valuable in point-of-care settings, where quick and accurate diagnostics are essential. INAAT is being widely adopted for the detection of infectious diseases, genetic disorders, and cancer biomarkers, making it an indispensable tool in modern healthcare. The technology's ability to deliver results quickly and with high accuracy is driving its integration into routine clinical diagnostics, especially in resource-limited settings where access to sophisticated laboratory infrastructure is limited.

How Are Technological Advancements Enhancing the Capabilities of INAAT?

Technological advancements are significantly enhancing the capabilities of INAAT, making it more robust, versatile, and accessible. Innovations in enzyme design and reaction chemistry are improving the sensitivity and specificity of INAAT assays, enabling the detection of low levels of nucleic acids in complex biological samples. Additionally, the development of portable and user-friendly devices that incorporate INAAT is expanding its use in field diagnostics and at-home testing. These advancements are particularly impactful in the fight against emerging infectious diseases, where rapid and decentralized testing is critical. The integration of INAAT with digital technologies and data analytics is also opening new possibilities for real-time monitoring of disease outbreaks and personalized medicine. These technological improvements are driving the adoption of INAAT across various sectors, from public health to personalized medicine.

What Challenges and Opportunities Exist in the INAAT Market?

Despite its growing adoption, the INAAT market faces several challenges, including the need for greater standardization, regulatory hurdles, and competition from established molecular diagnostics technologies. The lack of standardized protocols and reagents across different INAAT platforms can lead to variability in results, which is a concern for clinical applications. Additionally, the stringent regulatory requirements for diagnostic tests can slow down the commercialization of new INAAT products, particularly in highly regulated markets like the United States and Europe. However, these challenges also present opportunities for innovation and market growth. Companies that can develop standardized, easy-to-use INAAT kits with broad regulatory approval will be well-positioned to capitalize on the growing demand for rapid diagnostics. Moreover, the ongoing need for improved diagnostic tools in areas such as infectious disease control, cancer screening, and personalized medicine continues to drive interest and investment in INAAT.

What Factors Are Driving Growth in the INAAT Market?

The growth in the Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by several factors, including the increasing demand for rapid and accurate diagnostics, the rising prevalence of infectious diseases, and advancements in molecular biology. The ongoing need for point-of-care testing, particularly in the context of global health crises like the COVID-19 pandemic, has highlighted the importance of quick and reliable diagnostic tools, boosting the adoption of INAAT. Additionally, the expansion of INAAT applications beyond infectious disease testing, such as in oncology and genetic testing, is contributing to market growth. Technological advancements that improve the performance and ease of use of INAAT platforms are also playing a crucial role, as they enable wider adoption across different settings, from clinical laboratories to remote locations. As healthcare systems continue to emphasize the importance of early diagnosis and personalized treatment, the demand for INAAT is expected to grow, driving further advancements and market expansion.

Select Competitors (Total 12 Featured) -

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
    • Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rapid Diagnostics Spurs Growth in INAAT Market
    • Advancements in Molecular Biology Propel Innovation in INAAT Applications
    • Growing Use of INAAT in Point-of-Care Testing Expands Addressable Market
    • Shift Towards Decentralized and Home-Based Testing Strengthens Business Case for INAAT
    • Increased Focus on Early Detection of Infectious Diseases Drives Adoption of INAAT
    • Technological Innovations in Isothermal Amplification Accelerate Market Growth
    • Rising Need for Portable and User-Friendly Diagnostic Tools Throws Spotlight on INAAT
    • Expanding Applications of INAAT in Oncology and Genetic Testing Generate New Opportunities
    • Shift Towards Personalized Medicine Drives Innovation in INAAT Applications
    • Rising Demand for Temperature-Sensitive Logistics Spurs Growth in Isothermal Packaging Market
    • Advancements in Insulation Materials Propel Innovation in Isothermal Packaging
    • Growing Use of Isothermal Packaging in Pharmaceutical and Biotechnology Expands Addressable Market
    • Shift Towards Sustainable Packaging Solutions Strengthens Business Case for Isothermal Packaging
    • Increased Focus on Cold Chain Integrity Drives Adoption of Isothermal Packaging
    • Technological Innovations in Passive and Active Cooling Systems Accelerate Market Growth
    • Rising Need for Safe Vaccine Distribution Throws Spotlight on Isothermal Packaging
    • Expanding Applications of Isothermal Packaging in Food and Beverage Industry Generate New Opportunities
    • Shift Towards E-commerce and Direct-to-Consumer Deliveries Drives Demand for Isothermal Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Central & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Active Players in United States
    • TABLE 32: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Active Players in Japan
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Active Players in China
    • TABLE 59: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • Active Players in France
    • TABLE 80: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • Active Players in Germany
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • Active Players in United Kingdom
    • TABLE 107: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION